Item Type | Name |
Academic Article
|
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
|
Academic Article
|
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome.
|
Academic Article
|
Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report.
|
Academic Article
|
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus.
|
Academic Article
|
Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
|
Academic Article
|
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.
|
Academic Article
|
Weaning of immunosuppression in liver transplant recipients.
|
Academic Article
|
Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients.
|
Academic Article
|
Cryptococcosis in organ transplant recipients: an overview.
|
Academic Article
|
Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.
|
Academic Article
|
Patient participation in research among solid organ transplant recipients in the United States.
|
Academic Article
|
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
|
Academic Article
|
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature.
|
Academic Article
|
Adenosine Increases Hepatic Artery Flow in Liver Transplant Recipients: A Pilot Study.
|
Academic Article
|
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up.
|
Academic Article
|
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.
|
Academic Article
|
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up.
|
Academic Article
|
Kaposi's sarcoma in liver transplant recipients on FK506.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Academic Article
|
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients.
|
Academic Article
|
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
|
Academic Article
|
Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature.
|
Academic Article
|
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.
|
Academic Article
|
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.
|
Academic Article
|
Cardiac operations in solid-organ transplant recipients.
|
Academic Article
|
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.
|
Academic Article
|
Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients.
|
Academic Article
|
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients.
|
Academic Article
|
Nutritional management of intestinal transplant recipients.
|
Academic Article
|
Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
|
Academic Article
|
Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes.
|
Academic Article
|
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.
|
Academic Article
|
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients.
|
Academic Article
|
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management.
|
Academic Article
|
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients.
|
Academic Article
|
Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients?
|
Academic Article
|
Adjuvant bone marrow infusion in clinical organ transplant recipients.
|
Academic Article
|
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
|
Academic Article
|
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder.
|
Academic Article
|
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.
|
Academic Article
|
Present state of immunosuppressive therapy in liver transplant recipients.
|
Academic Article
|
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
|
Academic Article
|
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
|
Academic Article
|
Weaning of immunosuppression in long-term liver transplant recipients.
|
Academic Article
|
Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients.
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report.
|
Academic Article
|
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients.
|
Academic Article
|
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
|
Academic Article
|
Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient.
|
Academic Article
|
Influenza virus infection in adult solid organ transplant recipients.
|
Academic Article
|
[Analysis of causes of late mortality in liver transplant recipients].
|
Academic Article
|
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients.
|
Academic Article
|
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
|
Academic Article
|
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
|
Academic Article
|
Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications.
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
|
Grant
|
COMBINED BONE MARROW AND ORGAN TRANSPLANTATION IN HUMANS
|
Concept
|
Transplant Recipients
|